Oxbridge Re (OXBR) Registration Filing summary

Company overview and business model

• Operates as a specialty property and casualty reinsurer, focusing on fully collateralized reinsurance contracts for property and casualty insurers, primarily in the Gulf Coast region of the U.S., with an emphasis on Florida.

• Business includes traditional reinsurance and a Web3-focused tokenization segment, offering digital securities representing fractional interests in reinsurance contracts via its SurancePlus subsidiary.

• SurancePlus has launched several tokenized reinsurance securities (DeltaCat Re, EpsilonCat Re, ZetaCat Re, EtaCat Re) and plans further expansion into tokenization of other real-world assets.

• The company operates through subsidiaries: Oxbridge Reinsurance Limited, Oxbridge Re NS, SurancePlus Holdings Ltd., SurancePlus Inc., and DSN Blockchain Technologies Ltd.

• Not licensed as an insurer outside the Cayman Islands; all reinsurance contracts are fully collateralized and structured with liability limited to the value of assets held in trust.

Financial performance and metrics

• As of May 5, 2025, the aggregate market value of outstanding common stock held by non-affiliates was approximately $12.4 million, based on 7,442,922 shares outstanding and a share price of $1.83.

• SurancePlus private placements in 2023 and 2024 raised $2.45 million and $2.88 million, respectively, with proceeds used to purchase participating notes in affiliated reinsurance entities.

• The company held 10,549 shares of Jet.AI common stock after a reverse split and received $393,195 in sponsor payments and $141,000 from a bridge loan redemption in 2024.

Use of proceeds and capital allocation

• Net proceeds from tokenized securities offerings are used to purchase participating notes in affiliated reinsurance entities, which are then invested in collateralized reinsurance contracts.

• Proceeds from future securities offerings will be described in the applicable prospectus supplement; capital is deployed opportunistically to collateralize new reinsurance treaties and earn additional premium revenue.